Loyal
Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.
About Loyal
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia. By quantifying and regulating the processes of aging, the company aims to slow the emergence and mitigate the intensity of age-related ailments, thereby facilitating extended periods of improved health for both species.
Company Facts
- Headquarters
- San Francisco
- Founded
- 2019
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- late_stage_venture
- Total Funding
- $237,075,000
- Last Funding Type
- series_c
- Last Funding Date
- 2026-02-11
- Website
- https://loyalfordogs.com
Industries & Categories
Biotechnology, Pet, Veterinary
Social Links
Canonical: https://fsome.com/organization/loyal-23205 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.